Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
ALM
Alamar Biosciences
ALMR
EBITDA margin
EBITDA margin at other companies
Citigroup
C
124.1%
-9.7pp
Wells Fargo & Company
WFC
87.4%
-1.7pp
Morgan Stanley
MS
106.3%
-1.8pp
American Express
AXP
32.8%
-1.5pp
Charles Schwab Corporation
SCHW
65.4%
-5.9pp
Bank of America
BAC
102.4%
-13.1pp
Other financials
Income statement
See full
Revenue
$26.0M
+98.9%
Gross profit
$14.5M
+126%
Operating income
-$12.3M
-44.4%
Net income
-$21.3M
-178%
EPS (diluted)
-$1.74
-156%
Balance sheet
See full
Cash & equivalents
$64.6M
—
Total debt
$30.6M
—
Total equity
-$178.1M
—
Total assets
$186.5M
—
Cash flow
See full
Operating cash flow
-$20.3M
-55.7%
CapEx
$600.0K
+8.3%
Free cash flow
-$20.9M
-53.8%
Valuation
See full
Market cap
$1.96B
+37.6%
Enterprise value
$1.93B
—
Returns & leverage
See full
Debt / equity
-0.2×
—
Current ratio
5.9×
—
Watchlist
Screener
Filings
Earnings
Charts